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ABSTRACT Calcitonin is a polypeptidic hormone involved in calcium metabolism in the bone. It belongs to the amyloid protein
family, which is characterized by the common propensity to aggregate acquiring a b-sheet conformation and include proteins
associatedwith important neurodegenerative diseases. Herewe show for the ﬁrst time, to our knowledge, by transmission electron
microscopy (TEM) that salmon-calcitonin (sCT) forms annular oligomers similar to those observed for b-amyloid and a-sinuclein
(Alzheimer’s and Parkinson’s diseases). We also investigated the interaction between sCT and model membranes, such as
liposomes, with particular attention to the effect induced by lipid ‘‘rafts’’ made of cholesterol and GM1. We observed, by TEM
immunogold labeling of sCT, that protein binding is favored by the presence of rafts. In addition, we found by TEM that sCT
oligomers inserted in the membrane have the characteristic pore-like morphology of the amyloid proteins. Circular dichroism
experiments revealed an increase in b-content in sCT secondary structure when the protein was reconstituted in rafts mimicking
liposomes. Finally, we showed, by spectroﬂuorimetry experiments, that the presence of sCT allowedCa21 entry in rafts mimicking
liposomes loaded with the Ca21-speciﬁc ﬂuorophore Fluo-4. This demonstrates that sCT oligomers have ion-channel activity. Our
results are in good agreement with recent electrophysiological studies reporting that sCT forms Ca21-permeable ion channels in
planarmodelmembranes. It has been proposed that, beyond thewell-known interaction of themonomerwith the speciﬁc receptor,
the formation of Ca21 channels due to sCT oligomers could represent an extra source of Ca21 entry in osteoblasts. Structural and
functional data reported here support this hypothesis.
INTRODUCTION
Calcitonin (CT) is a 32-amino acid peptide involved in bone
calcium metabolism and clinically used in the treatment of
osteoporosis and other metabolic bone diseases. Its ability to
lower the plasma calcium concentration has been widely
studied and principally attributed to a strong inhibitory action
on osteoclast-mediated bone resorption (1). It has been dem-
onstrated that CT acts via a speciﬁc receptor found in many
cell types and tissues, suggesting diverse biological roles for
CT (2). In a recent work, Burns et al. demonstrated that CT
gene-related peptide (CGRP) elevates calcium and polarizes
membrane potential inMG-63 cells, an osteoblast cell line (3).
They suggested that the peptide stimulates Ca21 inﬂux in part
through L-type voltage-dependent channels.
In the study of CT physiological activity, its ability of
forming aggregates has seldom been considered. However,
CT is generally considered an amyloid protein due to its
aggregation behavior, which starts with the formation of
oligomers and eventually results in the deposition of ﬁbrils
and plaques. Some authors consider annular aggregates as
‘‘off-pathway’’ intermediates in the process of ﬁbrilization
(4). Unexpected results were obtained when it was shown
that CT is neurotoxic in vitro in the same manner and more
so than other amyloid proteins involved in neurodegenera-
tive pathologies (5,6). Many studies have been carried out to
investigate the relationship between structural features and
toxicity of amyloid proteins involved in diseases, such as
b-amyloid (bA) in Alzheimer’s disease (AD), a-Synuclein
(aS) in Parkinson’s disease (PD), prion in Creutzfeldt-
Jacob’s disease, inslet amyloid polypeptide in type II
diabetes, and others (7). Noticeably, Bucciantini et al. proved
that oligomers of proteins not associated with any disease are
also neurotoxic, suggesting that a shared structural feature of
the amyloid oligomers is at the basis of neurotoxicity (8).
This result is in good agreement with the general hypothesis
that protein misfolding, leading to the exposure of hydro-
phobic regions of proteins, renders them potentially toxic,
independent of their primary sequences (9). Misfolded
proteins should have the ability to aggregate and interact
with lipid membranes inducing cell damage and malfunction,
mainly mediated via the formation of ion channels (7).
Interestingly, this kind of toxicity named ‘‘hydrophobicity-
based toxicity’’ is similar to those described for antibacterial
toxins and viral proteins. This hypothesis is strongly sup-
ported by the observation that a single antibody, speciﬁcally
designed for bA, is able to recognize soluble oligomers of
widely varying primary sequences of amyloid proteins (10).
In this framework, Lashuel et al. found a common struc-
tural feature for the A30P and A53T aS mutations associated
with PD and bAARC (arctic mutation) associated with AD
(11). These proteins were shown to form oligomers rich in
b-sheet secondary structure, conformed as annular protoﬁbrils
with a diameter ranging 7–12 nm. Lin et al. (12) showed that
bA forms ion channels in lipid bilayers and imaged them for
the ﬁrst time by atomic force microscopy, suggesting that
Submitted December 9, 2005, and accepted for publication May 2, 2006.
Address reprint requests to Marco Diociaiuti, Tel.: 06-49902981; Fax:
06-49387140; E-mail: marco.diociaiuti@iss.it.
 2006 by the Biophysical Society
0006-3495/06/09/2275/07 $2.00 doi: 10.1529/biophysj.105.079475
Biophysical Journal Volume 91 September 2006 2275–2281 2275
they were composed of hexamers or tetramers. Moreover,
they measured the channel conductivity and tested the channel
biological activity on neurons, demonstrating that bA pore
formation induces rapid neuritic degeneration and death by a
Ca21-dependent toxicity mechanism (12). The pore forma-
tion and channel-like activity have been recently described
for other amyloid proteins, suggesting a possible common
mechanism for protein-misfolding diseases (13). A Ca21-
dependent toxicity, based on pore-like protoﬁbrils that cause
membrane permeabilization, has been proposed for aS by
Volles et al. in PD (14,15).
Theoretical models have been proposed to predict bA
peptide ability to insert in lipid bilayer (16). Molecular
dynamic simulation has been developed for bA ion-channel
formation in lipid bilayer on the basis of the amino acid se-
quence and experimental evidence of multilevel ion-channel
conductance. Several pore arrangements can be obtained, all
starting from a basic structure composed of a b-hairpin fol-
lowed by a helix-turn-helix motif (17).
Finally, it has been widely demonstrated that the second-
ary structure of membrane-bound bA and its ability to insert
into the lipid membrane are strongly affected by the lipid
composition. In particular, the importance of ‘‘raft-like’’
lipid domains in the membrane has been recently pointed
out, with particular attention to the presence of gangliosides
(18). In particular, Kakio et al. showed that low ganglioside
content favors the b-structure conformation (19,20).
Here we report for the ﬁrst time, to our knowledge,
transmission electron microscopy (TEM) evidence of salmon
calcitonin (sCT) annular oligomers very similar to those de-
scribed for other amyloid proteins. Moreover, sCT oligomers
form Ca21-permeable pores when inserted into rafts con-
taining liposomes. Circular dichroism (CD) data demonstrate
that the protein b-structure content increases during the
interaction with lipids.
MATERIALS AND METHODS
Preparation of sCT and sCT-liposome solutions
Lyophilized sCT (molecular mass ¼ 3432 Da) was purchased from
European Pharmacopoeia (EDQM, Strasbourg, France) and stored at18C
before use. L-a-phosphatidylcholinedipalmitoyl 99% (molecular mass ¼
734 Da), cholesterol 991% (molecular mass ¼ 387 Da), and mono-
sialoganglioside-GM1 95% from bovine brain (molecular mass ¼ 1564 Da)
were purchased from Sigma (Sigma Chemical, St Louis, MO) and stored at
18C before use. Fluo-4 was purchased from Molecular Probes (Eugene,
OR) and stored at 18C before use. All reagents were of analytical grade.
sCT 0.04 mg/ml solution (corresponding to 1.2 3 105 M protein content)
was prepared by dissolving the protein in the solid state in 5 mM sodium
phosphate buffer, pH 7.4—a condition that facilitates oligomerization (21).
To avoid the formation of ﬁbrils, the solutions were prepared immediately
before use. For the same reason, no stock solutions of protein were em-
ployed. For liposome preparation, two different lipid solutions were
prepared in chloroform: i) dipalmitoylphosphatidylcholine (DPPC), and ii)
DPPC/cholesterol/GM1 (50:46:4 mol %) by dissolving 3.7 mg of total lipids
in ;12 ml chloroform. sCT-containing liposomes were prepared by adding
to both lipid chloroform solutions 1.0 mg of sCT dissolved in 3 ml of
methanol. The obtained mixtures were placed in 100-ml round-bottomed
ﬂasks connected with a rotary evaporation unit, and the solvent was
evaporated to form sCT-lipid ﬁlms. The ﬁlms were dried by a vacuum pump
overnight. After drying, for CD and TEM analyses the ﬁlms were rehydrated
by 2.5 ml of phosphate buffer (5 mM, pH 7.4) for Ca21 inﬂux measurements
by 2.5 ml of HEPES/EGTA buffer (5 mM/0.1 mM, pH 7.4) added with Fluo-
4 (20 mM). The solutions were vortex mixed and then freeze thawed six
times from liquid nitrogen to 325 K. Dispersions were then extruded (10
times) through a 100-nm polycarbonate membrane (Whatman Nucleopore,
Clifton, NJ). The extrusions were carried out at 325 K, well above the
transition temperature of DPPC (315 K), using a 2.5-ml extruder (Lipex
Biomembranes, Vancouver, Canada). The solutions were then diluted 1:10
with buffer for CD and TEM analyses to obtain the same protein con-
centration of the ‘‘in buffer’’ experiments.
Transmission electron microscopy
Negative stain was obtained by a phosphotungstic acid (PTA) 2% w/v
solution buffered at pH ¼ 7.3 with NaOH. To avoid salt precipitation from
PTA and/or NaOH, which can be misinterpreted as actual structures, the
staining solution was ﬁltered before each preparation through polycarbonate
0.2-mm pore ﬁlters. A droplet of the suspension, containing liposomes and
proteins, was deposited onto 300 mesh copper grids for electron microscopy
and covered with a very thin amorphous carbon ﬁlm (;20 nm), and the
excess of liquid was removed by placing the grid on ﬁlter work. When the
grid was dried, a droplet of the staining solution was deposited and dried
following the same procedure. The heavy metal (W) surrounding the spec-
imen to be imaged scatters electrons more efﬁciently than the specimen itself,
providing high image contrast and allowing a detailed examination of the
structure (22). Moreover, heavy metal salts give good radiation protection
and maintain the structural integrity under the electron beam bombardment.
The samples were studied in a Zeiss 902 transmission electron microscope
(Zeiss, Jena, Germany) operating at 80 kV and equipped with an electron
energy loss ﬁlter. To enhance the contrast, the microscope was used in the
electron spectroscopy imaging (ESI) mode ﬁltering atDE¼ 0 eV. The image
acquisition was performed by a digital charge-coupled device camera model
HSC2, 1k for 1k pixels, (Proscan, Lagerlechfeld, Germany), thermostated by
a Peltier cooler model WKL 230 (LAUDA, Lauda-Ko¨nigshofen, Germany).
Image analysis and quantiﬁcation was performed by a digital image analyzer
analySIS 3.0 (SiS, Klausdorf, Germany). This software allows us to enhance
contrast and sharpness of the acquired images and to perform morphological
quantiﬁcation and statistics. The dimensional measurements were performed
after a careful magniﬁcation calibration of the whole imaging system based
on reference standards (cross grating and catalase crystal). For statistical
analysis, ;260 objects were considered from at least ﬁve ﬁelds.
sCT immunogold labeling
sCT liposomes were deposited onto thin carbon ﬁlm-coated grids for TEM
observation and air dried. For immunolocalization of sCT, samples were
preincubated for 5 min with 1% w/v bovine serum albumin (BSA) (Sigma
Chemical, St. Louis, MO) in phosphate buffer (0.1 M, pH 7.0) and then
incubated for 30 min at room temperature with mouse monoclonal anti-sCT
(Abcam, Cambridge, UK) at a concentration of 40 mg/ml. After washing for
10 min by ﬂoating the grids on phosphate buffer drops containing 1% w/v
BSA, samples were labeled with anti-mouse IgG 5-nm gold conjugate
diluted 1:10 (Sigma Chemical) for 30 min at room temperature. Control
samples were obtained as described above both by omission of the primary
antibody and on liposomes without sCT. After washing with phosphate
buffer, samples were negatively stained with PTA as described above.
Circular dichroism measurements
CD measurements were performed on a Jasco J-710 spectropolarimeter
(Jasco, Tokyo, Japan) in the far-ultraviolet region (260–195 nm). All spectra
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recorded were blank subtracted and were the mean of 8–16 different scans.
Quartz cells of 0.1-cm path length were employed. The spectral step
resolution was 0.1 nm and the speed scan 20 nm/min. All CD spectra were
reported as De¼ [Q]/3300, where [Q] is equal to (u3 100)/(l3 C) (u is the
measured ellipticity, C is the aminoacid concentration (¼ 1.23 1053 32),
and l is the path length in centimeter). Conformational analyses of CD
spectra were performed using the CDSSTR routine in a software package for
analyzing protein CD spectra via the Internet (23).
Ca21 inﬂux measurements
Ca21 inﬂux was measured using Fluo-4 as Ca21 indicator dye. Fluo-4 non-
entrapped in liposomes was separated by ﬁltration of 200 ml of liposomes
solution on a 1-ml Biorad (Hercules, CA) AM-15 gel column, equilibrated in
HEPES/EGTA buffer solution. Fractions containing liposomes were iden-
tiﬁed, with the ﬁrst ﬁve fractions that were combined and diluted to 2 ml.
Fluorescence measurements were performed at room temperature with a
Shimadzu (Columbia, MD) RF5001PC spectroﬂuorimeter in a 1-cm cuvette.
Excitation wavelength was 494 nm, whereas emission intensity was revealed
in the range 500–540 nm with slits set to 5 mm. Ca21 inﬂux was induced by
addition of 20 ml of 17.2 mM CaCl2 to the cuvette to obtain a ﬁnal calcium
concentration (0.172 mM) that does not cause fusion of liposomes and
dispersion of the dye in the bulk (24).
RESULTS AND DISCUSSION
In previous articles, we investigated the early stages of sCT
aggregation induced by ageing or oxidative conditions
(25,26). In this work we report, for the ﬁrst time, to our
knowledge, images of annular sCT oligomers of shape and
dimension very similar to bA and aS protoﬁbrils described
in the literature.
Fig. 1 shows negatively stained sCT annular oligomers
observed by TEM. The statistical distribution of their circle
perimeters is also shown. As reported for bA, also in the case
of sCT, the dominant symmetry was hexagonal even if small
globules and incomplete hexagons and/or linear protoﬁbrils
were also observed. Considering sCT low molecular weight,
the small globules could be oligomers themselves and the
annular structures could be assemblies of oligomers. This
structural feature has been described for bA and aS and is
considered to be at the basis of the ‘‘hydrophobicity-based
neurotoxicity’’. However, sCT is not directly involved in any
neurologic disease, even if, unexpectedly, its neurotoxicity
was observed in in vitro experiments (5,6).
We reconstituted sCT in DPPC liposomes and in rafts
containing liposomes (DPPC/cholesterol/monoganglioside-
GM1) to investigate the differences in the interaction of the
protein with these two model membranes, with particular
attention to the effect induced by the presence of lipid rafts
(27).
Immunogold labeling (Fig. 2) performed on sCT recon-
stituted in DPPC/cholesterol/GM1 liposomes allowed us to
demonstrate that the protein strongly binds to rafts contain-
ing liposomes, whereas plain DPPC liposomes were seldom
decorated, as we previously reported (26). This experiment
clearly indicates that a speciﬁc stronger interaction of sCT
with rafts occurred.
Fig. 3 shows TEM images of rafts containing liposomes
opened onto amorphous carbon substrate in the presence of
sCT. Gray islands surrounded by a dark background char-
acterize the images. They represent liposomes opened and
fused with each other, together with some unopened lipo-
somes that appear white (28). As can be observed in Fig. 3,
annular structures are easily recognizable on the dark back-
ground. Fig. 3, B and C, shows high magniﬁcation images
of two different annular oligomers not interacting with
FIGURE 1 sCT annular oligomers imaged by negative contrast TEM. The
inset shows the oligomer dimensional distribution (;260 objects). The
arrows indicate typical particles corresponding to each class.
FIGURE 2 sCT strongly binds to liposomes made of DPPC/cholesterol/
GM1 mimicking the occurrence of lipid rafts in the lipid membranes.
Immunogold labeling TEM, performed with anti-mouse IgG 5-nm gold
conjugate, clearly reveals that sCT is localized at the liposome surface.
Conversely, only a few gold particles have been found around liposomes
made of plain DPPC (26).
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liposomes, very similar in shape and dimension to those
reported in Fig. 1 in the absence of liposomes. More inter-
estingly, annular structures are also often detectable in lipo-
somes, as shown in Fig. 3, D and E. They seem to be smaller
than the isolated ones and characterized by a hexagonal
symmetry. The diameter of the internal pores of these struc-
tures was ;3 nm. This is compatible with the pore size of
most Ca21-permeable channels. In our opinion, they repre-
sent the direct visualization of the ion channels formed by
sCT in the lipid bilayer. It is worth noting that these annular
structures were never observed in the samples of both sCT-
and raft-free liposomes.
These ﬁndings strongly suggest that sCT annular oligo-
mers interact with the lipid bilayer-containing rafts, likely
forming Ca21-permeable channels, as previously proposed
by Stipani et al. (29) on the basis of electrophysiological
measurements. This is the ﬁrst direct evidence, to our
knowledge, of sCT channel formation in a lipid environment
and is in good agreement with the observation of pores
formed by many other amyloid proteins reconstituted in
liposomes and studied by atomic force microscopy (13).
Moreover, the hexagonal symmetry has been proposed in the
numerical simulation of the amyloid channels (17).
Fig. 4 shows CD spectra of sCT in the presence of
liposomes, with or without rafts, together with the relative
percentages of a-, b-, and unordered structures obtained by
deconvolution software (23). It is well known that the
aggregation process of amyloid proteins is generally accom-
panied by an increase in b-content (26,30). An evident rising
of the b-structure and a corresponding reduction of the
random-coil content can be observed in rafts containing
samples, whereas an essentially random-coil structure, very
similar to the typical sCT conformation in water (26), is
observed in plain DPPC liposomes. This conformational
change can be clearly attributed to the interaction of sCT
FIGURE 3 Rafts containing liposomes (gray islands) opened on amor-
phous carbon substrate for TEM in the presence of sCT (A). Isolated annular
structures, similar to those observed in Fig. 1, are clearly detectable as
‘‘doughnuts’’ in the dark background (high magniﬁcation in B and C). More
interestingly, pore-like structures are clearly observable in liposomes (high
magniﬁcation in D and E). Such features are quite repetitive and
characterized by a hexagonal symmetry.
FIGURE 4 CD spectra of sCT reconstituted in two different types of
liposomes: plain DPPC (dashed line) and DPPC/cholesterol/GM1 (contin-
uous line). Liposomes containing cholesterol/GM1 mimic the occurrence
of lipid rafts. The deconvolution of the CD curves gives (Random ¼ 56%;
Turn ¼ 15%; a-helix ¼ 5%; b-structures ¼ 23%) in the absence and
(Random ¼ 46%; Turn ¼ 19%; a-helix ¼ 5%; b-structures ¼ 30%) in the
presence of rafts. As can be observed the random-coil content decreases,
whereas b content rises in the presence of rafts.
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with the lipid rafts. Our result is very similar to that pub-
lished for ganglioside-bound bA (19) and is consistent with
the secondary structure foreseen in the theoretical models
(molecular dynamic) of ion channels (17).
Finally, Fig. 5 shows ﬂuorescence spectra of liposomes
loaded by Fluo-4. The presence of sCT reconstituted in rafts
containing liposomes allows Ca21 entry, whereas the
addition of Ca21 in the solution of plain rafts containing
liposomes does not alter the spectral shape. This result
demonstrates that Ca21 enter liposomes only when sCT is
present and strongly suggests that the pore-like structures
observed in the lipid bilayer are Ca21-permeable ion
channels.
In addition, we found that the presence of rafts is required
for Ca21 entry, since ﬂuorescence spectra of plain DPPC
liposomes do not evidence any signiﬁcant difference after
the reconstitution of sCT (Fig. 5, C and D). This result
supports the strategic role played by lipid rafts in facilitating
the membrane insertion of amyloid proteins.
All our results showed a dramatic similarity between bA,
aS, and sCT oligomers. In particular, we observed an an-
nular morphology for sCT similar to the one observed for
the A30P and A53T aS and bAARC mutations (11), and we
directly visualized that these structures actually interact with
lipids. Moreover, in agreement with CD data relative to other
amyloids (11,19), we found an increase in b secondary
structure when sCT interacts with model membranes con-
taining rafts. Finally, we show that annular oligomers are
permeable to Ca21, providing a demonstration of their func-
tional activity as in the case of bA. This activity is strictly
dependent on the presence of rafts, substantiating their role
in the possibly harmful pore formation.
All these structural and functional data are in good
agreement with the general hypothesis (9) that protein
FIGURE 5 Fluorescence spectra relative to
Ca21 inﬂux experiments performed on lipo-
somes loaded with Fluo-4. Liposomes made of
DPPC/cholesterol/GM1, mimicking the occur-
rence of lipid rafts (A, B), give a ﬂuorescence
signal after the addition of Ca21 only when sCT
is inserted in the membrane (B). Plain DPPC
liposomes (C, D) do not change the ﬂuores-
cence signal in the presence of sCT, demon-
strating that Ca21 enters liposomes only when
both sCT and rafts are present.
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misfolding leads to the exposure of hydrophobic regions and
renders proteins potentially cytotoxic via the formation of
ion channels. In addition, these results again corroborate the
hypothesis that amyloid proteins, although lacking sequence
homology, have a similar aggregation behavior. It is in-
teresting to note that CT has been found to be toxic for
neurons in vitro (5,6).
Most CT activities are mediated by a G protein-coupled
transmembrane receptor in osteoclasts (2). Recently, it has
been proposed that CT could form ion channels in osteoblast
plasma membrane, leading to Ca21 inﬂux (29). Here we
provide, for the ﬁrst time, experimental evidence that sCT
oligomerization actually leads to the formation of annular
structures able to interact with model membranes, in the
presence of lipid rafts, with Ca21-permeable channel activity.
CONCLUSIONS
The structural investigation here reported clearly indicates
that sCT, physiologically involved in the regulation of cal-
cium in the bone tissue, is able to form annular oligomers
during the early stages of ﬁbrillar aggregation. These olig-
omers are very similar to those observed for proteins in-
volved in important neurodegenerative diseases, such as AD
and PD. Moreover, the presence of rafts in model membranes
strongly favors the binding of sCT, with the consequent in-
crease of its b-secondary structure content. Conversely, sCT
interacts slightly with plain DPPC liposomes, without any
signiﬁcant conformational modiﬁcation (26). The annular
sCT oligomers have been directly visualized in the interac-
tion with raft-containing liposomes, forming amyloid ion
channels. Finally, we demonstrate that these structures play a
functional role, allowing Ca21 to cross the lipid membranes.
It is worth noting that in the absence of rafts, sCT recon-
stituted in plain DPPC liposomes does not induce Ca21 entry.
Recently, a mechanism has been proposed (schematically
represented in Fig. 6) based on the formation of pore-like
oligomers that penetrate the lipid bilayer to explain the
neurotoxicity of several amyloid proteins (15). However, we
wonder if this mechanism also has physiological signiﬁcance
in the case of the role played by CT in calcium homeostasis.
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